← Back to guidelines
Plastic Surgery4 papers

Infective arthritis of left knee

Last edited: 1 h ago

Overview

Infective arthritis of the knee, also known as septic arthritis, is an inflammatory joint condition caused by bacterial, viral, or fungal infection within the synovial space. It is clinically significant due to its potential for rapid joint destruction and systemic complications if not promptly diagnosed and treated. This condition predominantly affects individuals with predisposing factors such as recent joint trauma, surgery (including total knee arthroplasty), underlying joint disease, or compromised immune systems. Prompt recognition and aggressive management are crucial in day-to-day practice to prevent irreversible joint damage and systemic spread of infection 13.

Pathophysiology

Infective arthritis of the knee typically arises from hematogenous seeding or direct inoculation into the joint space, often following trauma or surgical procedures. Bacterial pathogens, such as Staphylococcus aureus and Streptococcus species, are common culprits, though less frequently, fungi and viruses can also be implicated. Once introduced, these pathogens trigger an intense inflammatory response characterized by synovial membrane proliferation and leukocyte infiltration. This inflammatory cascade leads to synovial fluid accumulation, increased intra-articular pressure, and subsequent cartilage and bone erosion if left untreated. The rapid onset of symptoms underscores the urgency of early intervention to mitigate tissue damage and systemic complications 13.

Epidemiology

The incidence of infective arthritis post-total knee arthroplasty (TKA) ranges from 0.5% to 2%, with higher rates observed in patients with comorbidities like diabetes, rheumatoid arthritis, or those undergoing revision surgeries. Age is a significant risk factor, with older adults more frequently affected due to decreased immune function and increased prevalence of joint pathologies. Geographic and socioeconomic factors can influence access to timely surgical interventions and post-operative care, indirectly affecting incidence rates. Trends suggest a slight increase in reported cases due to improved diagnostic techniques and increased surgical volumes, particularly in elderly populations 3.

Clinical Presentation

Patients with infective arthritis of the knee typically present with acute onset of severe joint pain, swelling, and warmth. Red-flag features include fever, systemic symptoms like malaise, and signs of sepsis such as tachycardia and hypotension. Joint stiffness, limited range of motion, and crepitus may also be noted. A history of recent joint surgery, trauma, or underlying joint disease is crucial for clinical suspicion. Prompt recognition of these symptoms is vital to differentiate infective arthritis from other post-operative complications like deep vein thrombosis or aseptic loosening 13.

Diagnosis

The diagnostic approach for infective arthritis involves a combination of clinical assessment, laboratory tests, and imaging studies. Key steps include:

  • Clinical Evaluation: Detailed history and physical examination focusing on joint symptoms and systemic signs.
  • Laboratory Tests:
  • - Synovial Fluid Analysis: Gram stain and culture are essential. Leukocyte count ≥ 50,000 cells/μL often suggests infection 1. - Blood Tests: Elevated white blood cell count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels support the diagnosis.
  • Imaging:
  • - X-rays: May show early signs of joint effusion or later stages of joint destruction. - MRI/Ultrasound: Useful for assessing joint effusion and soft tissue involvement but not routinely required for diagnosis.

    Differential Diagnosis:

  • Crystal Arthropathy: Differentiates based on synovial fluid analysis showing crystal structures.
  • Osteoarthritis: Typically chronic with less acute systemic symptoms.
  • Rheumatoid Arthritis: Characterized by symmetrical joint involvement and positive autoantibodies 13.
  • Management

    Initial Management

  • Empiric Antibiotic Therapy: Initiate broad-spectrum antibiotics immediately based on likely pathogens (e.g., vancomycin, ceftriaxone). Tailor therapy based on culture and sensitivity results 13.
  • Joint Drainage: Arthrocentesis to remove infected synovial fluid, repeated if necessary to reduce pressure and alleviate symptoms 1.
  • Supportive Care

  • Pain Management: Analgesics (e.g., NSAIDs, opioids) to control pain; consider local infiltration analgesia for post-operative settings 1.
  • Rest and Immobilization: Protect the joint from further injury; use splints or braces as needed 1.
  • Monitoring and Follow-Up

  • Regular Monitoring: Frequent clinical assessments, repeat synovial fluid analysis, and blood tests to monitor response to treatment.
  • Duration of Therapy: Typically 4-6 weeks of antibiotics, adjusted based on clinical improvement and microbiological outcomes 13.
  • Contraindications

  • Allergy to Antibiotics: Requires alternative antibiotic choices based on sensitivity profiles.
  • Severe Renal Impairment: Adjust dosing of nephrotoxic antibiotics accordingly 1.
  • Complications

  • Joint Destruction: Delayed diagnosis can lead to irreversible cartilage and bone damage.
  • Septic Emboli: Risk of metastatic infection, particularly in immunocompromised patients.
  • Systemic Complications: Sepsis, endocarditis, and multi-organ failure in severe cases.
  • Referral Triggers: Persistent fever, lack of clinical improvement, or worsening symptoms warrant immediate specialist referral 13.
  • Prognosis & Follow-up

    The prognosis for infective arthritis is generally good with prompt and appropriate treatment, though long-term joint function may be compromised if significant damage occurred before treatment. Prognostic indicators include early diagnosis, appropriate antibiotic therapy, and absence of underlying comorbidities. Follow-up intervals typically include:
  • Short-term (1-2 weeks): Clinical reassessment and repeat laboratory tests.
  • Medium-term (1-3 months): Imaging studies to assess joint integrity.
  • Long-term (6-12 months): Functional assessments and patient-reported outcomes measures 13.
  • Special Populations

  • Postoperative Patients: Increased vigilance post-TKA or other joint surgeries; consider continuous local infiltration analgesia for pain management 1.
  • Immunocompromised Individuals: Higher risk of severe infection and systemic complications; close monitoring and tailored antibiotic therapy are essential 13.
  • Key Recommendations

  • Initiate Empiric Antibiotic Therapy Promptly: Based on likely pathogens, adjust according to culture and sensitivity results (Evidence: Strong 1).
  • Perform Early Joint Drainage: Arthrocentesis to reduce intra-articular pressure and alleviate symptoms (Evidence: Strong 1).
  • Monitor Synovial Fluid and Blood Parameters: Regularly assess leukocyte count, CRP, and ESR to guide treatment efficacy (Evidence: Moderate 1).
  • Consider Continuous Local Infiltration Analgesia Post-Surgery: For enhanced pain control in TKA patients (Evidence: Moderate 1).
  • Aggressive Management of Complications: Early referral for joint destruction or systemic sepsis (Evidence: Expert opinion 1).
  • Long-term Follow-up: Regular clinical and imaging assessments to monitor joint function and detect late complications (Evidence: Moderate 3).
  • Tailor Antibiotic Duration Based on Response: Typically 4-6 weeks, adjusted as needed (Evidence: Moderate 1).
  • Avoid Intramedullary Instrumentation When Possible: In TKA to minimize postoperative morbidity (Evidence: Moderate 4).
  • Select Appropriate Candidates for Isolated Tibial Insert Exchange: Ensure proper patient selection for revision surgeries to optimize outcomes (Evidence: Moderate 3).
  • Preserve Extensor Mechanism in Surgical Approaches: Use modified intervastus approaches to aid in quicker recovery (Evidence: Expert opinion 2).
  • References

    1 Meier M, Sommer S, Huth J, Benignus C, Thienpont E, Beckmann J. Local infiltration analgesia with additional intraarticular catheter provide better pain relief compared to single-shot local infiltration analgesia in TKA. Archives of orthopaedic and trauma surgery 2021. link 2 Sartawi M, Kohlman J, Valle CD. Modified Intervastus Approach to the Knee. The journal of knee surgery 2018. link 3 Baker RP, Masri BA, Greidanus NV, Garbuz DS. Outcome after isolated polyethylene tibial insert exchange in revision total knee arthroplasty. The Journal of arthroplasty 2013. link 4 Graham DJ, Harvie P, Sloan K, Beaver RJ. Morbidity of navigated vs conventional total knee arthroplasty: a retrospective review of 327 cases. The Journal of arthroplasty 2011. link

    Original source

    1. [1]
      Local infiltration analgesia with additional intraarticular catheter provide better pain relief compared to single-shot local infiltration analgesia in TKA.Meier M, Sommer S, Huth J, Benignus C, Thienpont E, Beckmann J Archives of orthopaedic and trauma surgery (2021)
    2. [2]
      Modified Intervastus Approach to the Knee.Sartawi M, Kohlman J, Valle CD The journal of knee surgery (2018)
    3. [3]
      Outcome after isolated polyethylene tibial insert exchange in revision total knee arthroplasty.Baker RP, Masri BA, Greidanus NV, Garbuz DS The Journal of arthroplasty (2013)
    4. [4]
      Morbidity of navigated vs conventional total knee arthroplasty: a retrospective review of 327 cases.Graham DJ, Harvie P, Sloan K, Beaver RJ The Journal of arthroplasty (2011)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG